All News
Patient Who Had No Luck With GLP-1 Drugs Found Success With Surgery
(MedPage Today) -- This story is part of a series called "Ozempic: Weighing the Risks and Benefits." It was produced in part through a grant from the NIHCM Foundation.
Read MoreBariatric Surgeons Being Put Out of Work by GLP-1 Drugs
(MedPage Today) -- This story is part of a series called "Ozempic: Weighing the Risks and Benefits." It was produced in part through a grant from the NIHCM Foundation.
Read MoreSTAT+: PhRMA dues fell almost $100 million as major drugmakers exited
PhRMA's dues declined after the big drugmakers AbbVie, AstraZeneca, and Teva left the group.
Read MoreCongress Ditched Fix to Medicare Doc Pay Cut in Skinny Budget Bill
(MedPage Today) -- Following a tumultuous week of negotiations, Congress passed a skinny budget deal early Saturday morning, which President Biden signed into law, averting a government shutdown and
Read MoreAdding Daratumumab to VRd Boosts MRD Negativity in Transplant-Ineligible Myeloma
(MedPage Today) -- In an analysis of the phase III CEPHEUS trial presented at the American Society of Hematology annual meeting, adding daratumumab (Darzalex) to bortezomib (Velcade), lenalidomide (R
Read MoreNew BCMA-Directed Therapies Show Promise in Multiple Myeloma
(MedPage Today) -- Data presented at the American Society of Hematology (ASH) annual meeting highlighted advances in B-cell maturation antigen (BCMA)-directed therapies, including ABBV-383, a bispeci
Read MoreKing’s Christmas message to focus on healthcare workers
Monarch, who is undergoing cancer treatment, sought venue with strong health connections and community presenceThe king’s Christmas message will focus on the efforts of healthcare workers after a ye
Read MoreSpecialist Referrals Are Critical for Functional High-Risk Multiple Myeloma
(MedPage Today) -- For patients with functional high-risk multiple myeloma, timely referral to specialized centers is needed, since access to T-cell therapies and clinical trials may improve outcome
Read MoreChemo-Free Regimen for Ph+ ALL Yields High Rate of Deep MRD Negativity
(MedPage Today) -- Updated results of a phase II study presented at the American Society of Hematology annual meeting showed that a chemotherapy-free combination for newly diagnosed Philadelphia chro
Read MoreSTAT+: A tough year for health insurance stocks as patients get more care
This is the online version of STAT’s email newsletter Health Care Inc, delivered to your inbox every Monday. Sign up here.
Read More